L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma. 2009

Shengjin Li, and Young Suk Jo, and Jae-Hyek Lee, and Jeong-Ki Min, and Eung Seuk Lee, and Taewoo Park, and Jin-Man Kim, and Hyo Jeong Hong
Department of Pathology and Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon, Korea.

OBJECTIVE Cholangiocarcinomas (CC) are associated with poor survival, but diagnostic markers and therapeutic targets have not yet been elucidated. We previously found aberrant expression of L1 cell adhesion molecule in intrahepatic CC and a role for L1 in the progression of intrahepatic CC. Here, we analyzed L1 expression in extrahepatic CC (ECC) and evaluated its prognostic significance. METHODS We examined L1 expression in tumors from 75 ECC patients by immunohistochemistry. We analyzed the correlations between L1 expression and clinicopathologic factors as well as patient survival. RESULTS L1 was not expressed in normal extrahepatic bile duct epithelium but was aberrantly expressed in 42.7% of ECC tumors. High expression of L1 was detected at the invasive front of tumors and was significantly associated with perineural invasion (P < 0.01). Univariate analysis indicated that various prognostic factors such as histologic grade 3, advanced pathologic T stage and clinical stage, perineural invasion, nodal metastasis, and high expression of L1 were risk factors predicting patient survival. Multivariate analyses done by Cox's proportional hazards model showed that high expression of L1 (hazard ratio, 2.171; 95% confidence interval, 1.162-4.055; P = 0.015) and nodal metastasis (hazard ratio, 2.088; 95% confidence interval, 1.159-3.764; P = 0.014) were independent risk factors for patient death. CONCLUSIONS L1 was highly expressed in 42.7% of ECC and its expression was significantly associated with perineural invasion. High expression of L1 and nodal metastasis were independent poor prognostic factors predicting overall survival in patients with ECC.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D001650 Bile Duct Neoplasms Tumors or cancer of the BILE DUCTS. Bile Duct Cancer,Cancer of Bile Duct,Cancer of the Bile Duct,Neoplasms, Bile Duct,Bile Duct Cancers,Bile Duct Neoplasm,Cancer, Bile Duct,Cancers, Bile Duct,Neoplasm, Bile Duct
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Shengjin Li, and Young Suk Jo, and Jae-Hyek Lee, and Jeong-Ki Min, and Eung Seuk Lee, and Taewoo Park, and Jin-Man Kim, and Hyo Jeong Hong
October 2011, Human pathology,
Shengjin Li, and Young Suk Jo, and Jae-Hyek Lee, and Jeong-Ki Min, and Eung Seuk Lee, and Taewoo Park, and Jin-Man Kim, and Hyo Jeong Hong
July 2010, Clinical cancer research : an official journal of the American Association for Cancer Research,
Shengjin Li, and Young Suk Jo, and Jae-Hyek Lee, and Jeong-Ki Min, and Eung Seuk Lee, and Taewoo Park, and Jin-Man Kim, and Hyo Jeong Hong
October 2009, Anticancer research,
Shengjin Li, and Young Suk Jo, and Jae-Hyek Lee, and Jeong-Ki Min, and Eung Seuk Lee, and Taewoo Park, and Jin-Man Kim, and Hyo Jeong Hong
May 2022, Virchows Archiv : an international journal of pathology,
Shengjin Li, and Young Suk Jo, and Jae-Hyek Lee, and Jeong-Ki Min, and Eung Seuk Lee, and Taewoo Park, and Jin-Man Kim, and Hyo Jeong Hong
May 2017, Molecules and cells,
Shengjin Li, and Young Suk Jo, and Jae-Hyek Lee, and Jeong-Ki Min, and Eung Seuk Lee, and Taewoo Park, and Jin-Man Kim, and Hyo Jeong Hong
July 1998, Journal of neuroscience research,
Shengjin Li, and Young Suk Jo, and Jae-Hyek Lee, and Jeong-Ki Min, and Eung Seuk Lee, and Taewoo Park, and Jin-Man Kim, and Hyo Jeong Hong
May 2021, Diagnostics (Basel, Switzerland),
Shengjin Li, and Young Suk Jo, and Jae-Hyek Lee, and Jeong-Ki Min, and Eung Seuk Lee, and Taewoo Park, and Jin-Man Kim, and Hyo Jeong Hong
March 2016, Cancer biomarkers : section A of Disease markers,
Shengjin Li, and Young Suk Jo, and Jae-Hyek Lee, and Jeong-Ki Min, and Eung Seuk Lee, and Taewoo Park, and Jin-Man Kim, and Hyo Jeong Hong
June 2011, Journal of surgical oncology,
Shengjin Li, and Young Suk Jo, and Jae-Hyek Lee, and Jeong-Ki Min, and Eung Seuk Lee, and Taewoo Park, and Jin-Man Kim, and Hyo Jeong Hong
March 2012, Cancer letters,
Copied contents to your clipboard!